-
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
Gelissen, L. M. Y., Toorop, A. A., Schipper, P. M., Hoitsma, E., Zeinstra, E. M. P. E., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J., Wokke, B., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L. G. F. & Kloosterziel, M. E. & 11 others, , 25 Mar 2025, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.Research output: Contribution to journal › Article* › Academic › peer-review
-
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial
Coerver, E. M. E., Fung, W. H., de Beukelaar, J., Bouvy, W. H., Canta, L. R., Gerlach, O. H. H., Hoitsma, E., Hoogervorst, E. L. J., de Jong, B. A., Kalkers, N. F., van Kempen, Z. L. E., Lövenich, H., van Munster, C. E. P., van Oosten, B. W., Smolders, J., Vennegoor, A., Zeinstra, E. M. P. E., Barrantes-Cepas, M., Kooij, G. & Schoonheim, M. M. & 8 others, , 9 Dec 2024, (E-pub ahead of print) In: JAMA Neurology.Research output: Contribution to journal › Article* › Academic › peer-review
-
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Toorop, A. A., Wessels, M. H. J., Boonkamp, L., Gelissen, L. M. Y., Hoitsma, E., Zeinstra, E. M. P., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J. P., Wokke, B. H. A., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J. J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J. & Sinnige, L. G. F. & 12 others, , Nov 2024, In: Multiple Sclerosis Journal. 30, 13, p. 1683-1688 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
